Hi guys, Welcome to the Advanced Video Search Engine, and you are watching Updates in PARP inhibition for ovarian cancer. That video is uploaded by VJOncology at 2022-02-25T06:54:35-08:00. We are promoting this video only for entertainment and educational purpose only. So, I hope you like & enjoy it. [ItFkvbbHY54]
| Name | Updates in PARP inhibition for ovarian cancer |
| Video Uploader | Video From VJOncology |
| Upload Date | This Video Uploaded At 25-02-2022 14:54:35 |
| Video Discription | Don Dizon, FACP, FASCO, MD, Brown University, Providence, RI, describes developments in using PARP inhibitors for ovarian cancer, especially in patients with mutations in DNA damage repair genes such as BRCA. The discovery of certain genes that predict sensitivity to PARP inhibitors such as RAD51C or RAD51D will help identity patients who will benefit the most. Retreatment with PARP inhibitors in the second or third line setting following progression from maintenance therapy has also proven to be efficacious and further research is being conducted to assess novel combinations such as PARP inhibitors with immunotherapy or antiangiogenic drugs. This interview took place at the 7th Annual Practical Recommendations in Immuno and Molecular Oncology Meeting (PRIMO 2022). ItFkvbbHY54 |
| Category | Education |
| Tags | Speaker: Don Dizon | Institution: Brown University | Event: PRIMO 2022 | Format: Interview | Subject: Ovarian Cancer | Subject: Gynecological Cancer | Field: Field: Treatment | Field: Clinical Practice | PARP inhibitors | BRCA | RAD51C | RAD51D | maintenance therapy | immunotherapy | antiangiogenic drugs |
